Treatment Outcome of metastatic lesions from renal cell carcinoma underGoing Extra-cranial stereotactic body radioTHERapy: The together retrospective studySebastiano Buti, Nunziata D’Abbiero, Melissa Bersanelli et al.|Cancer Treatment and Research Communications|2019Cited by 25
217P Switching cyclin-dependent kinase inhibitors (CDK4/6i) in patients with hormone receptor-positive (HR+)/human epidermal growth factor-negative (HER2-) advanced breast cancer (ABC) who experienced unacceptable toxicityC. Benvenuti, Rita De Sanctis, J.Z. Zeghondy et al.|ESMO Open|2024Cited by 2